Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 21, 2015; 21(39): 10956-10981
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.10956
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.10956
ncRNA | Summary of findings/clinical relevance | q-PCR | Targets | Roles | Cases | Location | Ref. |
miR-23a/b | Implicated in the progression of GC. A potential prognosis marker | √ | Unknown | Unknown | 160 GC vs adjacent tissues | China | [264] |
miR-500 | Highly correlated with malignant progression and poor survival of GC | √ | CYLD, TAX1BP1, OTUD7B | Proliferation, survival and tumorigenicity | 10 GC vs adjacent tissues | China | [137] |
miR-374a | A promising therapeutic target | √ | SRCIN1 | Proliferation, tumor growth migration and invasion | 18 GC tissues vs adjacent tissues | China | [265] |
miR-199a-3p | A tumor promoter in GC targeting and inhibition of ZHX1; A potential target for GC prevention and therapy | √ | ZHX1 | Proliferation and apoptosis | 52 GC vs adjacent tissues | China | [266] |
miR-18a | A potential marker for risk stratification in the management of GC patients | √ | PIAS3, STAT3 | Unknown | 82 patients with GC and 65 healthy controls (plasma) | China | [204] |
miR-196a | A potential prognostic marker in GC | √ | Unknown | Differentiation and survival | 48 GC vs adjacent tissues | China | [240] |
miR-223, miR-16, miR-100 | Up-regulated in serum implicates their potential diagnostic value; Significantly elevated expression of the three miRNAs in advanced GC patients suggests their availability in cancer staging | √ | PIAS3 | Unknown | 50 GC patients and 47 healthy controls (serum) | China | [202] |
miR-135a-5p | Play a role in miRNA-135a-5p-AP-2α-BCL-2 pathway providing therapeutic potential for GC and solution for insensitivity of GC to chemotherapy | √ | AP-2α | Cell resistance to apoptosis, sensitivity to adriamycin | 20 GC vs adjacent tissues | China | [267] |
miR-199a-5p | SRF/miR-199a-5p/E-cadherin pathway promotes GC EMT and metastasis; A potential therapeutic target or biomarker for GC progression | √ | E-cadherin | Adhesion, invasion, and metastasis | 7 GC vs pairs adjacent tissues | China | [268] |
miR-25 | A potential biomarker for the prognosis of GC | √ | ERBB2, 1(TOB1) | Migration, invasion and proliferation | 33 GC vs paired adjacent tissues | China | [269] |
miR-942 | A potential drug response biomarker and therapeutic target for TRAIL resistant tumors | √ | ISG12a | Apoptosis | 28 GC tissues | China | [134] |
miR-196a/b | A potential therapeutic target in suppressing GC metastasis | √ | Radixin | Metastasis | 109 GC vs paired adjacent tissues | Taiwan | [172] |
miR-19a/b | A member of miR-19a/b facilitating GC cell migration, invasion and metastasis, implicating a novel mechanism for the malignant phenotypes of GC | √ | MXD1 | Migration and invasion | 141 GC vs paired adjacent tissues | China | [173] |
miR-423-5p | A potential therapeutic target | √ | TFF1 | Proliferation and invasion | 15 GC vs paired adjacent tissues | China | [270] |
miR-183-96-182 cluster | A novel role for GSK3β in the regulation of miR-183-96-182 biogenesis through β-catenin/TCF/ LEF-1 pathway in GC | √ | FoxO1 | Proliferation and migration | 8 GC vs paired adjacent tissues | United States | [83] |
miR-215 | Influencing cell proliferation by targeting RB1 | √ | RB1 | Proliferation | 51 GC vs paired adjacent tissues | China | [271] |
miR-17-92 cluster | Cluster including miR-19b, miR-20a and miR-92a associates with the development of GC stem cells; and miR-92a as a potential predictive prognostic marker for miR-92a in GC | √ | E2F1, HIPK1 | Self-renewal and proliferation | 97 GC specimens | China | [272] |
miR-296-5p | MiR-296-5p-CDX1-ERK1/2 axis play a role in gastric tumorigenesis; A potential therapeutic target | √ | CDX1 | Proliferation | 16 GC vs paired adjacent tissues | China | [273] |
miR-181a | Associated with increased risk and poor survival of GC | √ | MTMR3 | Unknown | 50 GC vs paired adjacent tissues | China | [274] |
miR-196a | Contributing to gastric carcinogenesis; A potential therapeutic target and prognostic factor | √ | p27 | Proliferation, apoptosis and tumorigenesis | 36 GC vs paired adjacent tissues | China | [275] |
miR-196b | Transcriptionally regulated by ETS2; A potential diagnostic marker and therapeutic target | √ | AnnexinA1, HOXB8 | Migration and invasion | 63 GC vs paired adjacent tissues | Taiwan | [276] |
miR-378 | Up-regulated in serum while down-regulated in GC tissues. A potential serum biomarker in GC detection | √ | Unknown | Unknown | 4 GC vs paired adjacent tissues, 40 GC serum samples vs 41 healthy controls | China | [277] |
miR-370 | Associated with GC progression by targeting TGFβ-RII | √ | TGFβ-RII | Migration | 33 GC vs adjacent tissues | Taiwan | [278] |
miR-192 miR-215 | Exerting cell growth and migration-promoting effects | √ | ALCAM | Migration, invasion, proliferation, cell cycle and apoptosis | 31 non-neoplastic stomach tissues and 25 GC tissues | United States | [279] |
miR-200b | A potential diagnostic and prognostic biomarker; A potential therapeutic target for peritoneal dissemination | √ | Unknown | Migration and invasion | 173 GC vs paired normal gastric epithelium tissues | Japan | [280] |
- Citation: Yang Q, Zhang RW, Sui PC, He HT, Ding L. Dysregulation of non-coding RNAs in gastric cancer. World J Gastroenterol 2015; 21(39): 10956-10981
- URL: https://www.wjgnet.com/1007-9327/full/v21/i39/10956.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i39.10956